Related Experiment Video

Updated: May 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Navigating the p53-MDM2 Landscape: Molecular Insights and Therapeutic Strategies

Mai A Mansour1, Ghaneya S Hassan1,2, Khaled A M Abouzid3

  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Badr University in Cairo, Cairo, Egypt.

Archiv Der Pharmazie
|May 28, 2026
PubMed

Insights

MDM2 inhibitors are crucial for cancer therapy by restoring tumor suppressor p53 activity. This review covers structure-based design and virtual screening for potent MDM2 inhibitors, discussing limitations and novel degradation strategies.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • MDM2 is a key oncogenic regulator that inhibits the tumor suppressor p53.
  • Disrupting the MDM2-p53 interaction is a vital strategy for cancer therapy.
  • Developing MDM2 inhibitors aims to restore p53 activity and induce cancer cell apoptosis.

Purpose of the Study:

  • To review advances in structure-based drug design (SBDD) and virtual screening (VS) for MDM2 inhibitors.
  • To summarize the development of potent inhibitors with enhanced binding affinity, selectivity, and pharmacokinetic profiles.
  • To discuss current limitations and explore innovative approaches like targeted protein degradation.

Main Methods:

  • Structure-based drug design (SBDD) approaches.
  • Virtual screening (VS) techniques.
  • Analysis of chemical scaffolds for MDM2 inhibitor synthesis.

Main Results:

  • Successful generation of potent MDM2 inhibitors through SBDD and VS.
  • Improved binding affinity, selectivity, and pharmacokinetic profiles of developed inhibitors.
  • Identification of limitations in chemical stability for current inhibitors.

Conclusions:

  • MDM2 inhibitors represent a promising therapeutic strategy for cancer.
  • Continued advancements in SBDD and VS are crucial for optimizing inhibitor design.
  • Targeted protein degradation offers a novel and innovative approach for MDM2 inhibition.
Keywords:
MDM2 inhibitorsPROTACapoptosisp53‐MDM2 interactionwild‐type p53

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...